How Pfizer Partner BioNTech Became a Leader in Coronavirus Vaccine Race - The Wall Street Journal

The outbreak, he believed, had the potential to grow into a pandemic.

The following Monday, the German scientist and chief executive of biotech firm BioNTech SE summoned his board to announce that the company, which had been developing next-generation cancer treatments, would start work on a Covid-19 vaccine.